Real-World Comparison of Cabazitaxel Versus 177Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer

Mike Wenzel; Florestan Koll; Benedikt Hoeh; Clara Humke; Carolin Siech; Nicolai Mader; Amir Sabet; Daniel Groener; Thomas Steuber; Markus Graefen; Tobias Maurer; Christian Brandts; Severine Banek; Felix K.H. Chun; Philipp Mandel

doi:10.2967/jnumed.124.268807

Research ArticleClinical Investigation

Real-World Comparison of Cabazitaxel Versus ¹⁷⁷Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer

Mike Wenzel, Florestan Koll, Benedikt Hoeh, Clara Humke, Carolin Siech, Nicolai Mader, Amir Sabet, Daniel Groener, Thomas Steuber, Markus Graefen, Tobias Maurer, Christian Brandts, Severine Banek, Felix K.H. Chun and Philipp Mandel

Journal of Nuclear Medicine January 2025, 66 (1) 61-66; DOI: https://doi.org/10.2967/jnumed.124.268807

Mike Wenzel

1Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Florestan Koll

1Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Benedikt Hoeh

1Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Clara Humke

1Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carolin Siech

1Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nicolai Mader

2Department of Nuclear Medicine, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amir Sabet

2Department of Nuclear Medicine, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel Groener

2Department of Nuclear Medicine, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas Steuber

3Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany;

4Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Markus Graefen

3Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tobias Maurer

3Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany;

4Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christian Brandts

5Hematology/Oncology, Department of Medicine, University Hospital Frankfurt, Goethe University, Frankfurt Am Main, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Severine Banek

1Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Felix K.H. Chun

1Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philipp Mandel

1Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany;

3Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Individuals

Non-Member Login

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 1

January 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Real-World Comparison of Cabazitaxel Versus 177Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Real-World Comparison of Cabazitaxel Versus ¹⁷⁷Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine Jan 2025, 66 (1) 61-66; DOI: 10.2967/jnumed.124.268807

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Real-World Comparison of Cabazitaxel Versus ¹⁷⁷Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine Jan 2025, 66 (1) 61-66; DOI: 10.2967/jnumed.124.268807

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

177Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?
Reply to "177Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?"

Google Scholar

Keywords

mCRPC
PFS
OS
survival
177Lu

Main menu

User menu

Search

Real-World Comparison of Cabazitaxel Versus ¹⁷⁷Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer

Individuals

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords